Cancer-Specific Synthetic Lethality Between ATR and CHK1 Kinase Activities

Cell Reports - United States
doi 10.1016/j.celrep.2015.12.032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

ATR and DNA-PK/CHK1 Elicit Distinct Responses in Cancer Cells

Cancer Discovery
Oncology
2015English

Ranking Differential Drug Activities From Dose-Response Synthetic Lethality Screens

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2016English

E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer

Cancer Discovery
Oncology
2018English

Immunotherapy Exposes Cancer Stem Cell Resistance and a New Synthetic Lethality

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Synthetic Lethality as a Targeted Approach to Advanced Prostate Cancer

2012English

Phosphatase Type 2a-Dependent and -Independent Pathways for ATR Phosphorylation of Chk1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Kinase- And Rapsyn-Independent Activities of the Muscle-Specific Kinase (MuSK)

Neuroscience
Neuroscience
2004English

KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer

Cancer Research
Cancer ResearchOncology
2013English

Polo-Like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy